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Abstract IRF-8/ICSBP and IRF-1 are IRF family members
whose expression is induced in response to IFN-Q in macro-
phages. IL-12 is a cytokine produced in macrophages that plays
a critical role in host defense. IFN-Q and bacterial lipopolysac-
charide (LPS) induce IL-12p40 transcription, which is necessary
for the production of IL-12. We have previously shown that IL-
12p40 expression is impaired in ICSBP-de¢cient mice and that
transfection of ICSBP together with IRF-1 can activate IL-
12p40 expression in mouse macrophage cells. To further study
the role of ICSBP and IRF-1, we investigated murine IL-12p40
promoter activity in the macrophage cell line RAW 264.7. We
show here that co-transfection of ICSBP and IRF-1 synergisti-
cally stimulates IL-12 promoter activity to a level comparable
to that induced by IFN-Q/LPS. Mutation of the Ets or NFUB
site previously shown to be important for IL-12p40 transcription
did not abolish the activation by ICSBP and IRF-1. However,
mutation of the ISRE-like site found downstream from the
NFUB and C/EBP sites abrogated the activation by ICSBP
and IRF-1. Together, these results indicate that ICSBP and
IRF-1 cooperatively stimulate murine IL-12 transcription
through a novel regulatory element in the murine promoter.
5 2002 Federation of European Biochemical Societies. Pub-
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1. Introduction
Interleukin-12 (IL-12) is a heterodimeric cytokine composed
of two disul¢de-linked subunits of 35 (p35) and 40 (p40) kDa.
While p35 is expressed constitutively in a broad array of cells,
IL-12p40 is expressed speci¢cally in macrophage/dendritic
cells upon activation as well as B cells and neutrophiles [1].
IL-12 exerts an anti-microbial e¡ect, primarily because it in-
duces expression of interferon-Q (IFN-Q) in T cells or NK cells,
thereby promoting the development of Th1 responses and
inhibiting Th2 responses [2]. The ¢nding that IL-12 p40
knockout mice have a severely depressed Th1 response sup-
ports the role of IL-12 in the Th1 response and resistance to
infections [3^6]. Previously, treatment of macrophages with
IFN-Q followed by LPS has been shown to potently induce
IL-12p40 mRNA expression, where IFN-Q is thought to exert
a priming e¡ect [7].
Several laboratories have studied the transcriptional regu-
lation of IL-12p40 [8,9]. Studying the mouse IL-12 promoter,
Murphy et al. reported that the Rel/NFUB site is important
for promoter activity stimulated by IFN-Q and LPS [10]. A
later study by Plevy et al. demonstrated a role for the C/EBP
site, located downstream from the Rel/NFUB site, which is
shown to cooperate with the Rel/NFUB site [11]. On the other
hand, Ma et al. studying the human promoter revealed that
the Ets site, residing upstream from the Rel/NFUB site, con-
served in the human and mouse genes, is required for stimu-
lation by IFN-Q and LPS [12]. These authors showed that a
sequence containing the Ets site binds to an inducible protein
complex containing several factors. We have previously re-
ported that IL-12 expression is impaired in IRF-8/interferon
consensus sequence binding protein (ICSBP) knockout mice
and that such animals are highly susceptible to infections of
Toxoplasma gondii and Leishmania major because they do not
produce IFN-Q [13,14]. Later we showed that IRF-8/ICSBP
can enhance human and mouse IL-12p40 promoter activity
when transfected into ICSBP3/3 and +/+ mouse macro-
phages [15]. Further, ICSBP was assembled into a multi-pro-
tein complex containing interferon regulatory factor-1 (IRF-1)
that bound to the Ets site in the promoter identi¢ed by Ma et
al. [7]. In this study we further investigated the role of ICSBP
in the activation of the murine IL-12 p40 promoter, which
slightly di¡ers from its human counterpart in nucleotide se-
quence. We show that ICSBP and IRF-1 synergistically stim-
ulate murine IL-12p40 promoter activity through a novel site
that resembles the interferon stimulated responsive element
(ISRE), a target element for the IRF family that is located
downstream from the NFUB site. Our results further support
a critical role for ICSBP and IRF-1 in IL-12p40 expression.
2. Materials and methods
2.1. Cell culture and reagents
The murine macrophage-like cells RAW 264.7 cells were main-
tained in RPMI 1640 medium supplemented with glutamine, antibi-
otics and 10% FBS (endotoxin 6 1 ng/ml). Mouse IFN-Q was a gift
from Toray. Lipopolysaccharide (LPS) was purchased from Difco
Laboratories.
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2.2. Plasmid construction
A PCR fragment generated from the promoter region of the murine
IL-12 gene was cloned into the pGL2 luciferase vector (Promega,
Madison, WI, USA) [10,11,16]. Deletion constructs were generated
by PCR and sequenced by the dideoxy method. Expression vectors
for ICSBPLK440 were generated under the control of the L-actin
promoter as described [15], and IRF-1pcDNA3.1, under the control
of CMV promoter. All plasmids used for transfection assays were
prepared by CsCl double banding or with an EndoFree plasmid kit
(QIAGEN) to minimize endotoxin contamination.
2.3. Transfection assay
RAW cells were transfected with 400 ng of luciferase reporter or
given amounts of expression vectors (up to 200 ng DNA) using lipo-
fectamine PLUS (Life Technologies). The amount of transfected
DNA was adjusted with empty vectors LK440 or pcDNA3.1. Five
hours after transfection, the cell culture medium was changed to com-
plete medium containing 10% FBS and stimulated with IFN-Q (1000
u/ml) for 16^20 h, followed by LPS (100 ng/ml) for an additional 4^8
h. Cells were assayed for luciferase activity using the dual luciferase
assay system (Promega). Reporter activity is shown as the avarage of
three determinations and standard error.
2.4. DNA a⁄nity binding assay
Biotinylated DNA fragments encompassing the ISRE-like site of
IL-12p40 were synthesized from the sequence (356 to 375) using
biotinylated primer as detailed in [15,17]. Three hundred nanograms
of biotinylated DNA was conjugated to 20 Wl of streptavidin-bound
magnetic beads (Dynabeads, M280, Dynal, Lake Success, NY, USA)
in TGEDN bu¡er containing 10 mM Tris^HCl, pH 8.0, 1 mM
EDTA, 0.1 M NaCl, 1 mM DTT, 0.1% NP-40 and 10% glycerol
and then incubated with 500 Wg of RAW cell nuclear extract and 20
Wg of salmon sperm DNA (Sigma) at 4‡C for 2 h. Beads were washed
in TGEDN bu¡er, and bound materials were eluted in 20 Wl of the
same bu¡er and boiled. Eluted materials were separated by 10% SDS^
PAGE and detected by immunoblot analysis using rabbit anti-ICSBP
[15,17], anti-IRF-1 [15,17] and anti-YY1 antibodies (Santa Cruz) with
the enhanced chemiluminescence kit (Amersham). Nuclear extracts
were prepared from RAW cells treated with IFN-Q (1000 U/ml) for
20 h.
2.5. RT-PCR
Quantitative PCR was performed as previously described [15].
cDNAs were prepared from 1 Wg of total RNA using Molony murine
leukemia virus reverse transcriptase (Life Technologies). Dilluted
cDNA was subscribed to PCR for IL-12 (35 cycles) and HPRT (28
cycles), using each primer as previously reported [15].
3. Results
3.1. IRF-8/ICSBP and IRF-1 activate the murine IL-12p40
promoter in RAW264.7 cells
It has been shown that the IL-12p40 gene is expressed in the
macrophage cell line RAW264.7 (hereafter: RAW) following
treatment with IFN-Q followed by LPS [7,15]. We tested the
activity of a luciferase reporter fused to a 425-bp murine IL-
12 p40 promoter in RAW cells. The 425 promoter contains
the NFUB, C/EBP and Ets site, previously reported to con-
tribute to the transcription of IL-12p40 (Fig. 1). As seen in
Fig. 2, IFN-Q and LPS alone modestly stimulated reporter
activity, while IFN-Q plus LPS gave V a ¢ve-fold increase,
indicating that this promoter can be activated by IFN-Q/LPS
in RAW cells. Previous study with gene knockout mice
showed that both ICSBP and IRF-1 play a role in IL-12p40
expression [15]. The two factors are synergistically induced by
IFN-Q and LPS in macrophages [18]. The aim of this work has
TTCTTTGGGC CTGTAACACC TACTTATTTG ATTGTGGCAT GAACCATGAA
CTCGGTTTGG GGCAAGTCCT TCCTTTTTCT GCACTCTGTG GAATCGGGAG
AGGTTAGCCA TTGCCGCCTC TATTCACCTT AGGCATGATC TAAACAGAAA
TTACTATCTC TGCCTCCTTC CTTTTTCCAC ACCCCGAAGT CATTTCCTCT
TAACCTGGGA TTTCGACGTC TATATTCCCT CTGTATGATA GATGCACTCA
GGGAGGCAAG GGGGGGAGGG AGGAACTTCT TAAAATTCCC CCAGAATGTT
TTGACACTAG TTTTCAGTGT TGCAATTGAG ACTAGTCAGT TTCTACTTTG
GGTTTCCATC AGAAAGTTCT GTAGGAGTAG AGTATATAAG CACCAGGAGC
AGCCAAGGCA GCAGAAGGAA CAGT
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Fig. 1. A schematic representation of the truncated murine IL-12
promoter. Murine IL-12p40 promoter-luciferase plasmids were gen-
erated by PCR using murine genomic DNA. The mutations disrupt
the Ets site (3220/3217) and the NFUB half-site (3133/3131,
3128/126). Bold-faced type indicates GAS/C/EBP, Ets, NFUB, C/
EBP and ISRE regions. Disrupted sequences of Ets and NFUB are
underlined. Substition mutants were created in the context of an
ISRE site (375/356) indicated by lower-case letters.
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Fig. 2. Murine IL-12 promoter activated RAW 264.7 cells in the
presence of IFN-Q/LPS. The IL-12 promoter (425 bp) was trans-
fected into RAW cells and the cells were treated with IFN-Q and
LPS as described in Materials and methods. Each result represents
the meanQS.D. of data from three to ¢ve experiments.
FEBS 26702 23-10-02
A. Masumi et al./FEBS Letters 531 (2002) 348^353 349
been to study whether exogenous ICSBP and IRF-1 stimulate
IL-12p40 reporter activity, and if so, to determine the regu-
latory element responsible for the activity of these factors. As
shown in Fig. 3A, transfection of ICSBP and IRF-1 alone
stimulated IL-12 promoter activity only slightly. However,
co-transfection of both factors led to a stronger reporter ac-
tivity comparable to that seen by IFN-Q and LPS (Fig. 3A).
To determine the element through which ICSBP and IRF-1
activate the IL-12p40 reporter, mutant reporters in which the
Ets or NFUB sites were mutated were tested (see Fig. 1 for
mutated nucleotides). Neither mutation a¡ected the ability of
ICSBP and IRF-1 to stimulate reporter activity, indicating
that these factors act through a site distinct from the Ets or
NFUB site (Fig. 3A). To further delineate the region necessary
for activation by ICSBP and IRF-1, reporters with progres-
sive 5P deletions (see Fig. 1) were tested. The data in Fig. 3B
show that while reporters with 190-bp and 110-bp IL-12p40
promoters could be stimulated by ICSBP and IRF-1, the re-
porter containing only a 63-bp promoter could not, indicating
that the critical element resides downstream of position
V398 and upstream of position V351. We tested the e¡ect
of ICSBP and IRF-1 on endogenous IL-12 gene expression in
RAW cells. Transfection of ICSBP induced IL-12 gene mod-
estly; however, co-transfection of both factors IRF-1/ICSBP
led to a much greater level of stimulation of IL-12 gene ex-
pression (Fig. 3C).
3.2. ICSBP and IRF-1 bind to the ISRE-like site in the IL-12
promoter
Inspection of the sequence between 398 and 351 reveals
the presence of an element resembling the ISRE (see Fig. 1A
TTTCTSCTTTGGGTTTC). A typical ISRE contains a direct
repeat of the GAAA motif with a spacer of several nucleotides
[19]. To test the possibility that ICSBP and IRF-1 bind to this
element, we performed DNA a⁄nity binding assays. The bio-
tinylated ISRE-like element was immobilized on magnetic
beads and incubated with nuclear extracts from RAW cells
treated with or without IFN-Q for 16 h. As shown in the input
lanes in Fig. 4A, IFN-Q enhanced the expression of IRF-1 and
ICSBP. Both proteins in IFN-Q-treated samples were bound to
the ISRE-conjugated beads (Fig. 4A). In contrast, untreated
samples showed no binding. YY1, expressed in RAW cells
with and without IFN-Q, did not bind to the ISRE beads,
indicating the speci¢city of the binding.
To con¢rm that the ISRE-like element is important for the
activity of ICSBP/IRF-1, a mutant IL-12 reporter containing
4-bp mutations in the ISRE was tested in co-transfection as-
says. As shown in Fig. 4B, the wild-type 110-bp IL-12p40
reporter was activated by co-transfection of ICSBP and
IRF-1. In contrast, the mutant reporter was not activated
by ICSBP and IRF-1. These results indicate that ICSBP and
IRF-1 act through the ISRE-like element to stimulate IL-
12p40 promoter activity in macrophages. To test whether
the IFN-Q/LPS treatment induce IL-12 promoter activity
through ISRE-like site, RAW cells were transfected with
425 ISRE mutant reporter and treated with IFN-Q/LPS.
IFN-Q/LPS synergistically stimulated 425 wild-type promoter
(Figs. 4C and 2), whereas synergistical e¡ect of IFN-Q/LPS
was not observed in RAW cells transfected with 425 ISRE
mutant reporter (Fig. 4C). These results indicated that coop-
erative regulation of ICSBP and IRF-1 on an ISRE-like site
are important for IL-12 stimulation by IFN-Q/LPS.
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Fig. 3. Stimulation of murine IL-12 promoter activity by ICSBP
and IRF-1. A: RAW cells were transfected with the murine IL-12
promoter (400 ng) and its mutant luciferase reporters (400 ng) with
ICSBP (100 ng), IRF-1 (100 ng) and control vector (100 ng). B:
ICSBP and IRF-1 were transfected into RAW cells with IL-12 dele-
tion reporters. Luciferase assay was performed 24 h post-transfec-
tion. Each result represents the meanQS.D. of data from three to
¢ve experiments. C: Stimulation of endogenous IL-12 transcription
by co-transfection of ICSBP and IRF-1. RAW cells were transfected
with ICSBP (200 ng), IRF-2 (200 ng) and empty vector. Total
RNA was isolated and RT-PCR was performed by using oligonu-
cleiotids speci¢c for murine IL-12 or HPRT as described in Materi-
als and methods.
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3.3. The role of coactivator p300 in activating the IL-12p40
promoter
IRF-1 has been shown to interact with the coactivator
p300/CBP [20]. With their histone acetylase activity, the co-
activators regulate the transcription of many genes. Further-
B
A
Fig. 5. E¡ect of p300 on IRF-1 and ICSBP-stimulated IL-12 pro-
moter activity. A: p300 (100 ng and 200 ng) was co-transfected
with ICSBP (100 ng), IRF-1 (100 ng) and a 110-bp IL-12 reporter
(400 ng) into RAW cells. B: p300 (100 ng and 200 ng) was trans-
fected with IRF-1 (100 ng) and ISG15-ISRE reporter (400 ng) into
RAW cells. Luciferase assay was performed 24 h post-transfection.
Each result represents the meanQS.D. of data from three to ¢ve ex-
periments.
6
Fig. 4. ICSBP and IRF-1 bind to the ISRE-like site of the IL-12
promoter. A: Three hundred nanograms of biotinylated DNA con-
taining the ISRE-like site (356 to 375) was conjugated to 20 Wl of
magnetic beads and incubated with 500 Wg of nuclear extract from
RAW cells treated with or without IFN-Q. The beads were washed,
and bound materials were eluted and detected by immunoblot as-
says. B: ICSBP, IRF-1 and the IL-12 reporter containing an ISRE-
like site or mutant ISRE-like site were transfected into RAW cells.
Luciferase assay was performed 24 h post-transfection. Each result
represents the meanQ the standard deviation of data from three to
¢ve experiments. C: IL-12 reporter containing an ISRE-like site
(425 WT) or mutant ISRE-like site (425 ISRE mutant) was trans-
fected into RAW cells. Cells were treated with IFN-Q/LPS and lucif-
erase assay was performed as described in Materials and methods.
Each result represents the meanQS.D. of data from three to ¢ve ex-
periments.
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more, we have previously shown that IRF-1 can be acetylated
by p300 [21]. It was of interest to determine whether activa-
tion of the IL-12p40 promoter by ICSBP and IRF-1 involves
p300. RAW cells were co-transfected with ICSBP and IRF-1
in the absence or presence of p300 (Fig. 5A). Co-transfection
of p300 and IRF-1 without ICSBP did not stimulate IL-12p40
promoter activity. Similarly, co-transfection of p300 and
ICSBP without IRF-1 failed to stimulate the promoter. How-
ever, when p300 was the co-transfected with ICSBP and IRF-
1, promoter activity was markedly enhanced in a p300-dose-
dependent manner. These results suggest that the coactivator
p300 is recruited to the IL-12p40 promoter depending on both
ICSBP and IRF-1. Unlike the IL-12p40 promoter, which re-
quired both factors, p300 enhanced the activity of a classic
ISRE promoter from the ISG15 gene [17] when transfected
with IRF-1 alone (without ICSBP) (Fig. 5B). The ISRE pro-
moter is composed of GGAAACCGAAAC (Fig. 5B), which
is related to, but distinct from, that of the IL-12p40 element.
4. Discussion
In this study, we have identi¢ed a novel cis-acting element
in the murine IL-12p40 promoter, upon which ICSBP/IRF-8
and IRF-1 act to enhance transcription. The element, resem-
bling the ISRE, resides downstream from the NFUB and C/
EBP site. This element has not been implicated in the activa-
tion of IL-12p40 before. In our previous analysis of the hu-
man IL-12p40 promoter, ICSBP and IRF-1 were also found
to synergistically stimulate transcription, but through another
upstream regulatory element [7,15]. In the present study, a
mutation of the Ets site in the murine promoter did not elim-
inate the activation by ICSBP and IRF-1, while a mutation in
the ISRE-like element completely abrogated it. We also
showed that both ICSBP and IRF-1 expressed in IFN-Q-
stimulated RAW cells bind to the ISRE-like element, support-
ing the direct involvement of ICSBP and IRF-1 in IL-12p40
promoter activity. These results indicate that ICSBP and IRF-
1 can activate both the human and murine IL-12p40 pro-
moter, but through di¡erent elements. It is of note that
although the Ets site and the ISRE-like element are similar
between the human and murine IL-12p40 promoters, there are
subtle nucleotide di¡erences, mostly in the £anking sequences
(the murine Ets TTTCCTCTTAACCT vs. human Ets TTT-
CCTCTTAGTT and murine ISRE TTTCTACTTTGGG-
TTTCC vs. human ISRE TTTCTAGTTTAAGTTTG). These
small sequence di¡erences may dictate the relative importance
of the two elements for eliciting the activity of ICSBP and
IRF-1. On the other hand, these elements may in fact be
functional in both species, depending on the type of stimula-
tion and cellular environment.
Previous reports on ICSBP3/3 and IRF-13/3 mice are
consistent with the importance of ICSBP and IRF-1 in regu-
lating IL-12p40 transcription [22,13,14]. The impaired IL-12
expression in these mice is associated with a failure to express
IFN-Q and to mount an e¡ective host defense upon exposure
to various infectious pathogens [23].
In this study and previous reports [7,15], ICSBP acted as an
activator for both mouse and human IL-12p40 transcription.
However, ICSBP was originally shown to repress the tran-
scription of interferon-inducible promoters carrying the
ISRE by repressing IRF-1 activity [24,25]. Several recent stud-
ies have indicated that this transcription factor has dual ac-
tivity and can activate transcription from a subgroup of ISRE
[26] and related GAS sequences [27].
It is worth noting that the ISRE-like element in the IL-
12p40 promoter di¡ers from the classic ISRE that tends to
contain two GAAA motifs with a 2^3-bp spacer. The element
in the IL-12p40 contains two GAAA motifs with a much
longer spacer of 8 bp. Furthermore, the 3P part of the
GAAA motif overlaps with an Ets site of a GGAA motif.
It is likely that the binding of ICSBP and IRF-1 on the IL-
12p40 element is distinct from that on the classic ISRE.
Although it is not clear how ICSBP and IRF-1 make contact
with the element, the way in which ICSBP and IRF-1 bind the
DNA may in£uence their functionality as a transcription fac-
tor. It may also in£uence how a coactivator such as p300 and
PCAF is recruited to the element. Previously we noted that
p300 can bind to IRF-1 and IRF-2 [21]. In the present study,
p300 enhanced the IL-12 promoter activity when both ICSBP
and IRF-1 were co-transfected, but not when only IRF-1 was
transfected. In contrast, p300 enhanced ISG15 ISRE pro-
moter activity with IRF-1 alone (Fig. 5B). In conclusion,
the present study revealed that ICSBP/IRF-8 can activate
the murine IL-12p40 promoter in cooperation with IRF-1
through a novel ISRE-like element. Further work is required
to elucidate the mechanism by which this element recruits
ICSBP, IRF-1 and other transcription factors and activates
transcription.
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